After the Gairdner Award—Where Next? (Gairdner International Symposium)

Schedule

Thu Oct 22 2026 at 09:00 am to 01:00 pm

UTC-04:00
Location

MaRS Centre Auditorium | Toronto, ON

Gairdner Laureates and leading researchers explore how breakthrough discoveries evolve into transformative therapies.
About this Event

This symposium brings together 2026 Gairdner Laureates and leading researchers to explore how breakthrough discoveries evolve into transformative therapies and shape the future of medicine.


Featured Speakers Include:

  • Jeffery Kelly, 2026 Canada Gairdner International Award winner
  • Matthias Mann, 2026 Canada Gairdner International Award winner
  • Aaron Phillips, 2026 Peter Gilgan Canada Gairdner Momentum Award winner
  • Megan Levings, Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia and BC Children’s Hospital Research Institute.
  • Felicia Pagliuca, Senior Vice President, Cell and Genetic Therapy Research at Vertex Pharmaceuticals


Unable to attend in person? Join us via livestream: https://bit.ly/GSW-2026-Livestream


Agenda

🕑: 09:00 AM
Chair Remarks
🕑: 09:05 AM
Tafamidis Led to 10 Drugs for Treating Amyloid Diseases: What Remains to Do?

Info: Dr. Jeffery W. Kelly, H. Lutcher Brown Professor of Chemistry, Department of Chemistry, Scripps Research, La Jolla, United States


🕑: 09:45 AM
Leveraging heart-brain connections for novel treatments

Info: Dr. Aaron Phillips, Associate Professor, Departments of Clinical Neurosciences, Cardiac Sciences, Physiology and Pharmacology, University of Calgary; Associate Dean, Innovation and Commercialization, Cumming School of Medicine, University of Calgary, Canada


🕑: 10:25 AM
Regulating Human Immunity

Info: Dr. Megan Levings, PhD, Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia; Scientist, BC Children's Hospital Research Institute


🕑: 11:00 AM
Bio Break
🕑: 11:25 AM
Stem Cell Derived Islets for Type 1 Diabetes

Info: Dr. Felicia Pagliuca, PhD, Senior Vice President, Cell and Genetic Therapy Research & Site Head, Vertex Pharmaceuticals, San Diego, CA, USA


🕑: 12:05 PM
Mass spectrometry-based proteomics: from precision instrumentation to saving p

Info: Dr. Matthias Mann, Director of Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany


🕑: 12:40 PM
Chair Closing Remarks

Where is it happening?

MaRS Centre Auditorium, Lower Concourse, Toronto, Canada
Tickets

USD 0.00

Know what’s Happening Next — before everyone else does.
Gairdner Foundation
Host or PublisherGairdner Foundation

Ask AI if this event suits you